New EU framework on product safety: Beginning on 13 December 2024, the new EU General Product Safety Regulation (“GPSR”) will replace national product safety regimes

Effective from 13 December 2024, the new General Product Safety Regulation (GPSR) (EU) 2023/988 will replace outdated national laws and the General Product Safety Directive (2001/95/EC), introducing harmonized rules across all EU member states. This regulation represents a significant enhancement of general product safety legislation and is set to impact …

Read more

On 28 September 2022, the Commission has published its proposal for a revised Product Liability Directive, and, for the first time a targeted harmonization of national liability rules for AI.

In a nutshell, the Commission´s proposal of a new Product Liability Directive implements rather extensive rules presuming defectiveness of the product and/or the causal link between its defectiveness and the damage for the benefit of the claimants. In addition, disclosure obligations for defendants are implemented to ease the position of …

Read more

NOVACOS ADVISES 3M IN LANDMARK PROCEEDINGS ON THE MEANING OF THE TERM “HYPOALLERGENIC” ALL THE WAY TO THE FEDERAL COURT OF JUSTICE

Düsseldorf. The term “hypoallergenic” is used today for a wide range of consumer products, from plasters to cosmetics to baby food. Now the highest court has ruled: The statement “hypoallergenic” does not mean that a product is completely free of allergenic ingredients. Rather, consumers correctly assume that only fewer of …

Read more

NOVACOS Partner Dr. Marc Oeben holds lecture “National Pharmaceutical Liability Law III – Practical Implementation and International Pharmaceutical Liability Law” at the Philipps-University Marburg

Our partner Dr. Marc Oeben holds the lecture “National Pharmaceutical Liability Law III – Practical Implementation and International Pharmaceutical Liability Law” as part of the additional qualification in pharmaceutical law at the Philipps University of Marburg. With the additional qualification in pharmaceutical law, the Faculty of Law at the Philipps …

Read more

NOVACOS advises Triton on investment in Bergman Clinics

Düsseldorf, 9 March 2021 – NOVACOS has advised investment firm Triton Fund V alongside De Brauw Blackstone Westbroek on an agreement to invest in Bergman Clinics, one of the leading chains of independent clinics in the Netherlands, Germany and Scandinavia. This investment will be in partnership with the current shareholders …

Read more

NOVACOS advised Oakley Capital on the acquisition of WindStar Medical from NuCom Group (majority-owned by ProSiebenSat1)

NOVACOS advised Oakley Capital on the acquisition of WindStar Medical from NuCom Group (majority-owned by ProSiebenSat1).

WindStar Medical is a leading supplier of health products in Germany and develops and distributes high-quality medical products and over-the-counter medicines for drugstores, supermarkets and pharmacies. Since 2016, the company has been part of …

Read more